Poly Medicure Ltd Reports Q1 FY26 Results: 4.8% YoY Consolidated Revenue Growth; 20.1% Domestic Market Revenue Growth

Poly Medicure Ltd, a leading Medical Device company in India, has announced its unaudited consolidated and standalone financial results for the quarter ended on June 30, 2025. The company reported a 4.8% YoY growth in consolidated revenue and a 20.1% YoY growth in domestic market revenue. The gross profit margin stood at 68.4%, reflecting a 170BPS expansion on a YoY basis. The operating EBITDA margin was 26.3% and the PAT margin was 20.9%. The company has a zero net debt position and adequate liquidity of Rs. 1,248.6 Cr. as of 30th Jun’25. The renal care business maintained its strong growth trajectory with a 46.2% YoY growth. The company also initiated India’s First international Clinical registry of 2000 patients to evaluate performance and safety of RisoR Everolimus Eluting Stent System across India and Europe.